Ligand validation:3V8L

BT5: BIOTINYL-5-AMP

BT5 is a Ligand Of Interest in 3V8L designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3V8L_BT5_A_500	13%	6%	0.278	0.822	2.41	2.81	6	13	2	0	100%	1
3RKW_BT5_A_500	48%	3%	0.196	0.944	3.2	3.39	15	20	4	0	97%	0.9737
3RIR_BT5_A_500	41%	0%	0.225	0.943	3.49	6.73	13	20	3	0	100%	0.7021
2DVE_BT5_B_1301	90%	14%	0.077	0.959	2.2	1.87	10	12	0	0	100%	1
2DEQ_BT5_B_1301	89%	8%	0.082	0.961	2.42	2.36	6	11	0	0	100%	1
4OP0_BT5_A_301	89%	15%	0.085	0.963	2.05	1.93	6	9	0	0	100%	1
2DJZ_BT5_A_1301	87%	14%	0.086	0.957	2.29	1.81	11	10	0	0	100%	1
2DXU_BT5_B_2301	85%	14%	0.09	0.955	2.19	1.85	11	12	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.